268 related articles for article (PubMed ID: 15539465)
1. Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.
Schoonenboom NS; Mulder C; Vanderstichele H; Van Elk EJ; Kok A; Van Kamp GJ; Scheltens P; Blankenstein MA
Clin Chem; 2005 Jan; 51(1):189-95. PubMed ID: 15539465
[TBL] [Abstract][Full Text] [Related]
2. Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.
Simonsen AH; Bahl JM; Danborg PB; Lindstrom V; Larsen SO; Grubb A; Heegaard NH; Waldemar G
J Neurosci Methods; 2013 May; 215(2):234-40. PubMed ID: 23537933
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting.
Gervaise-Henry C; Watfa G; Albuisson E; Kolodziej A; Dousset B; Olivier JL; Jonveaux TR; Malaplate-Armand C
J Alzheimers Dis; 2017; 57(2):437-445. PubMed ID: 28269771
[TBL] [Abstract][Full Text] [Related]
4. Importance and impact of preanalytical variables on Alzheimer disease biomarker concentrations in cerebrospinal fluid.
Le Bastard N; De Deyn PP; Engelborghs S
Clin Chem; 2015 May; 61(5):734-43. PubMed ID: 25869575
[TBL] [Abstract][Full Text] [Related]
5. Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42).
Kaiser E; Schönknecht P; Thomann PA; Hunt A; Schröder J
Neurosci Lett; 2007 May; 417(2):193-5. PubMed ID: 17408854
[TBL] [Abstract][Full Text] [Related]
6. Instability of cerebrospinal fluid after delayed storage and repeated freezing: a holistic study by drop coating deposition Raman spectroscopy.
Klener J; Hofbauerová K; Bartoš A; Ríčný J; Rípová D; Kopecký V
Clin Chem Lab Med; 2014 May; 52(5):657-64. PubMed ID: 24293450
[TBL] [Abstract][Full Text] [Related]
7. Effects of certain pre-analytical factors on the performance of plasma phospho-tau217.
Bali D; Hansson O; Janelidze S
Alzheimers Res Ther; 2024 Feb; 16(1):31. PubMed ID: 38331843
[TBL] [Abstract][Full Text] [Related]
8. Towards a unified protocol for handling of CSF before β-amyloid measurements.
Janelidze S; Stomrud E; Brix B; Hansson O
Alzheimers Res Ther; 2019 Jul; 11(1):63. PubMed ID: 31324260
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40).
Vanderstichele H; Demeyer L; Janelidze S; Coart E; Stoops E; Mauroo K; Herbst V; François C; Hansson O
Alzheimers Res Ther; 2017 Jun; 9(1):40. PubMed ID: 28587660
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay.
Rozga M; Bittner T; Höglund K; Blennow K
Clin Chem Lab Med; 2017 Aug; 55(10):1545-1554. PubMed ID: 28160541
[TBL] [Abstract][Full Text] [Related]
11. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM
JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467
[TBL] [Abstract][Full Text] [Related]
12. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
Vanderstichele H; Bibl M; Engelborghs S; Le Bastard N; Lewczuk P; Molinuevo JL; Parnetti L; Perret-Liaudet A; Shaw LM; Teunissen C; Wouters D; Blennow K
Alzheimers Dement; 2012 Jan; 8(1):65-73. PubMed ID: 22047631
[TBL] [Abstract][Full Text] [Related]
13. Importance of cerebrospinal fluid storage conditions for the Alzheimer's disease diagnostics on an automated platform.
Ferrer R; Zhu N; Arranz J; Porcel I; El Bounasri S; Sánchez O; Torres S; Julve J; Lleó A; Blanco-Vaca F; Alcolea D; Tondo M
Clin Chem Lab Med; 2022 Jun; 60(7):1058-1063. PubMed ID: 35405043
[TBL] [Abstract][Full Text] [Related]
14. Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?
Sancesario GM; Esposito Z; Nuccetelli M; Bernardini S; Sorge R; Martorana A; Federici G; Bernardi G; Sancesario G
Exp Neurol; 2010 Jun; 223(2):371-6. PubMed ID: 19664624
[TBL] [Abstract][Full Text] [Related]
15. Chasing the Effects of Pre-Analytical Confounders - A Multicenter Study on CSF-AD Biomarkers.
Leitão MJ; Baldeiras I; Herukka SK; Pikkarainen M; Leinonen V; Simonsen AH; Perret-Liaudet A; Fourier A; Quadrio I; Veiga PM; de Oliveira CR
Front Neurol; 2015; 6():153. PubMed ID: 26217300
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
17. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
[TBL] [Abstract][Full Text] [Related]
18. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
[TBL] [Abstract][Full Text] [Related]
19. Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform.
Delaby C; Muñoz L; Torres S; Nadal A; Le Bastard N; Lehmann S; Lleó A; Alcolea D
Clin Chim Acta; 2019 Mar; 490():98-101. PubMed ID: 30579960
[TBL] [Abstract][Full Text] [Related]
20. Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.
Tapiola T; Pirttilä T; Mikkonen M; Mehta PD; Alafuzoff I; Koivisto K; Soininen H
Neurosci Lett; 2000 Feb; 280(2):119-22. PubMed ID: 10686392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
